MetaCap

Vertex Pharmaceuticals Insider Trades

NASDAQ: VRTXHealth CareBiotechnology: Pharmaceutical PreparationsUSD

505.64+3.33 (+0.66%)

At close: Oct 7, 4:00 PM ET · Delayed 15 min

Last 12 months

Purchases
0 · $0
Sales
34 · $37.39M
Shares bought / sold
0 / 77.82K
Net activity
Net selling $37.4 million

Vertex Pharmaceuticals insider activity

Over the last 12 months, Vertex Pharmaceuticals insiders reported 48 transactions on SEC Form 4: 0 open-market purchases and 34 sales. Insiders bought $0 and sold $37.4 million worth of stock, for net insider selling of $37.4 million. The largest seller was Kewalramani Reshma, with $19.7 million in reported sales.

The most recent filing shows van Grunsven Jasper (EVP, CP and NPPO) reporting a transaction in 8,682 shares on Sep 8, 2026. Insider sales are common for compensation, tax and diversification reasons, while open-market purchases are rarer; tracking both helps put VRTX's ownership changes in context.

Summary generated from market data by MetaCap's automated system. Methodology

VRTX insider transactions

Vertex Pharmaceuticals insider transactions
DateInsiderTypeSharesValueFiling
Sep 8, 2026van Grunsven JasperEVP, CP and NPPOAward8,682—Form 4
Aug 28, 2026Ambrose KristenSVP & Chief Accounting OfficerAward5,000—Form 4
Aug 27, 2026SACHS BRUCE IDirectorGift6,000—Form 4
Jul 21, 2026Sachdev AmitEVP Chief Patient & Ext Af OffAward8,251—Form 4
Jul 21, 2026Tatsis OuraniaEVP, Chief Reg. & Quality Off.Award8,251—Form 4
Jul 2, 2026McKechnie DuncanEVP, Chief Commercial OfficerSale1,541$799.78KForm 4
Jul 2, 2026Tatsis OuraniaEVP, Chief Reg. & Quality Off.Sale1,500$787.49KForm 4
Jul 1, 2026Liu JoyEVP and Chief Legal OfficerSale828$416.24KForm 4
Jun 26, 2026Bozic CarmenEVP and CMOSale596$287.57KForm 4
Jun 18, 2026Bozic CarmenEVP and CMOSale1,020$471.41KForm 4
Jun 15, 2026Bozic CarmenEVP and CMOSale4,062$1.83MForm 4
Jun 5, 2026Bozic CarmenEVP and CMOSale1,745$785.25KForm 4
Jun 1, 2026Liu JoyEVP and Chief Legal OfficerSale828$364.25KForm 4
May 29, 2026Bozic CarmenEVP and CMOSale1,974$888.30KForm 4
May 15, 2026Bozic CarmenEVP and CMOSale1,354$613.97KForm 4
May 15, 2026Bunnage Mark E.EVP, Chief Scientific OfficerSale33$14.96KForm 4
May 12, 2026Bozic CarmenEVP and CMOSale6,988$3.14MForm 4
May 4, 2026Bhatia Sangeeta N.DirectorSale318$134.75KForm 4
May 1, 2026Bhatia Sangeeta N.DirectorAward943—Form 4
May 1, 2026Garber Alan MDirectorAward472—Form 4
May 1, 2026Liu JoyEVP and Chief Legal OfficerSale1,104$469.22KForm 4
May 1, 2026MCKENZIE DIANADirectorDisposition796—Form 4
May 1, 2026MCKENZIE DIANADirectorAward943—Form 4
May 1, 2026Schneider JenniferDirectorDisposition796—Form 4
May 1, 2026Schneider JenniferDirectorAward472—Form 4
May 1, 2026Thornberry NancyDirectorDisposition398—Form 4
May 1, 2026Thornberry NancyDirectorAward472—Form 4
May 1, 2026Upadhyay SuketuDirectorDisposition796—Form 4
Apr 1, 2026Liu JoyEVP and Chief Legal OfficerSale978$439.29KForm 4
Mar 27, 2026Bozic CarmenEVP and CMOSale2,329$1.05MForm 4
Mar 13, 2026Bozic CarmenEVP and CMOSale2,329$1.12MForm 4
Mar 11, 2026McKechnie DuncanEVP, Chief Commercial OfficerSale2,633$1.31MForm 4
Mar 4, 2026McKechnie DuncanEVP, Chief Commercial OfficerSale2,437$1.16MForm 4
Mar 2, 2026Liu JoyEVP and Chief Legal OfficerSale892$442.40KForm 4
Feb 27, 2026Kewalramani ReshmaCEO & PresidentSale1,725$857.24KForm 4
Feb 27, 2026Kewalramani ReshmaCEO & PresidentSale5,995$2.97MForm 4
Feb 27, 2026Kewalramani ReshmaCEO & PresidentSale15,580$7.72MForm 4
Feb 27, 2026Kewalramani ReshmaCEO & PresidentSale3,498$1.73MForm 4
Feb 27, 2026Kewalramani ReshmaCEO & PresidentSale2,520$1.24MForm 4
Feb 27, 2026Kewalramani ReshmaCEO & PresidentSale949$466.24KForm 4
Feb 27, 2026Kewalramani ReshmaCEO & PresidentSale2,725$1.34MForm 4
Feb 27, 2026Kewalramani ReshmaCEO & PresidentSale460$225.09KForm 4
Feb 27, 2026Kewalramani ReshmaCEO & PresidentSale3,278$1.60MForm 4
Feb 27, 2026Kewalramani ReshmaCEO & PresidentSale2,510$1.22MForm 4
Feb 27, 2026Kewalramani ReshmaCEO & PresidentSale240$115.88KForm 4
Feb 27, 2026Kewalramani ReshmaCEO & PresidentSale120$57.78KForm 4
Feb 27, 2026Kewalramani ReshmaCEO & PresidentSale400$191.90KForm 4
Feb 27, 2026Bozic CarmenEVP and CMOSale2,329$1.12MForm 4

Transaction codes follow SEC Form 4: P = open-market purchase, S = open-market sale, A = grant or award, M = option exercise, F = shares withheld for taxes. About Form 4

Related